This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kern, W. V.
Right arrow Articles by Levy, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kern, W. V.
Right arrow Articles by Levy, S. B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2000, p. 814-820, Vol. 44, No. 4
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli

W. V. Kern,1,* M. Oethinger,2,3 A. S. Jellen-Ritter,1 and S. B. Levy3

Section of Infectious Diseases and Clinical Immunology, Department of Medicine, University Hospital and Medical Center, D-89070 Ulm,1 and Heart and Diabetes Center NRW, D-32545 Bad Oeynhausen,2 Germany, and Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts 021113

Received 9 August 1999/Returned for modification 8 November 1999/Accepted 22 December 1999

Mutations in loci other than genes for the target topoisomerases of fluoroquinolones, gyrA and parC, may play a role in the development of fluoroquinolone resistance in Escherichia coli. A series of mutants with increasing resistance to ofloxacin was obtained from an E. coli K-12 strain and five clinical isolates. First-step mutants acquired a gyrA mutation. Second-step mutants reproducibly acquired a phenotype of multiple antibiotic resistance (Mar) and organic solvent tolerance and showed enhanced fluoroquinolone efflux. None of the second-step mutants showed additional topoisomerase mutations. All second-step mutants showed constitutive expression of marA and/or overexpressed soxS. In some third-step mutants, fluoroquinolone efflux was further enhanced compared to that for second-step mutants, even when the mutant had acquired additional topoisomerase mutations. Attempts to circumvent the second-step Mar mutation by induction of the mar locus with sodium salicylate and thus to select for pure topoisomerase mutants at the second step were not successful. At least in vitro, non-target gene mutations accumulate in second- and third-step mutants upon exposure to a fluoroquinolone and typically include, but do not appear to be limited to, mutations in the mar or sox regulons with consequent increased drug efflux.

* Corresponding author. Mailing address: Medizinische Universitätsklinik und Poliklinik, D-89070 Ulm, Germany. Phone: 49-731-502 4423. Fax: 49-731-502 4488. E-mail: winfried.kern{at}medizin.uni-ulm.de.

Antimicrobial Agents and Chemotherapy, April 2000, p. 814-820, Vol. 44, No. 4
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Fu, Y., Guo, L., Xu, Y., Zhang, W., Gu, J., Xu, J., Chen, X., Zhao, Y., Ma, J., Liu, X., Zhang, F. (2008). Alteration of GyrA Amino Acid Required for Ciprofloxacin Resistance in Klebsiella pneumoniae Isolates in China. Antimicrob. Agents Chemother. 52: 2980-2983 [Abstract] [Full Text]  
  • Abouzeed, Y. M., Baucheron, S., Cloeckaert, A. (2008). ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium. Antimicrob. Agents Chemother. 52: 2428-2434 [Abstract] [Full Text]  
  • Vali, L., Davies, S. E., Lai, L. L. G., Dave, J., Amyes, S. G. B. (2008). Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates. J Antimicrob Chemother 61: 524-532 [Abstract] [Full Text]  
  • Schumacher, A., Trittler, R., Bohnert, J. A., Kummerer, K., Pages, J.-M., Kern, W. V. (2007). Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother 59: 1261-1264 [Abstract] [Full Text]  
  • Bohnert, J. A., Schuster, S., Fahnrich, E., Trittler, R., Kern, W. V. (2007). Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). J Antimicrob Chemother 59: 1216-1222 [Abstract] [Full Text]  
  • Chen, S., Cui, S., McDermott, P. F., Zhao, S., White, D. G., Paulsen, I., Meng, J. (2007). Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials. Antimicrob. Agents Chemother. 51: 535-542 [Abstract] [Full Text]  
  • Pumbwe, L., Glass, D., Wexler, H. M. (2006). Efflux Pump Overexpression in Multiple-Antibiotic-Resistant Mutants of Bacteroides fragilis.. Antimicrob. Agents Chemother. 50: 3150-3153 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • Lindgren, P. K., Marcusson, L. L., Sandvang, D., Frimodt-Moller, N., Hughes, D. (2005). Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in Escherichia coli Implicated in Urinary Tract Infections. Antimicrob. Agents Chemother. 49: 2343-2351 [Abstract] [Full Text]  
  • Bohnert, J. A., Kern, W. V. (2005). Selected Arylpiperazines Are Capable of Reversing Multidrug Resistance in Escherichia coli Overexpressing RND Efflux Pumps. Antimicrob. Agents Chemother. 49: 849-852 [Abstract] [Full Text]  
  • Tavio, M. M, Vila, J., Perilli, M., Casanas, L. T, Macia, L., Amicosante, G., Jimenez de Anta, M. T (2004). Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains. J Med Microbiol 53: 1119-1122 [Abstract] [Full Text]  
  • Levy, D. D., Sharma, B., Cebula, T. A. (2004). Single-Nucleotide Polymorphism Mutation Spectra and Resistance to Quinolones in Salmonella enterica Serovar Enteritidis with a Mutator Phenotype. Antimicrob. Agents Chemother. 48: 2355-2363 [Abstract] [Full Text]  
  • Ling, J. M., Chan, E. W., Lam, A. W., Cheng, A. F. (2003). Mutations in Topoisomerase Genes of Fluoroquinolone-Resistant Salmonellae in Hong Kong. Antimicrob. Agents Chemother. 47: 3567-3573 [Abstract] [Full Text]  
  • Komp Lindgren, P., Karlsson, A., Hughes, D. (2003). Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections. Antimicrob. Agents Chemother. 47: 3222-3232 [Abstract] [Full Text]  
  • Schneiders, T., Amyes, S. G. B., Levy, S. B. (2003). Role of AcrR and RamA in Fluoroquinolone Resistance in Clinical Klebsiella pneumoniae Isolates from Singapore. Antimicrob. Agents Chemother. 47: 2831-2837 [Abstract] [Full Text]  
  • Saenz, Y., Zarazaga, M., Brinas, L., Ruiz-Larrea, F., Torres, C. (2003). Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J Antimicrob Chemother 51: 1001-1005 [Abstract] [Full Text]  
  • Webber, M. A., Piddock, L. J. V. (2003). The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51: 9-11 [Full Text]  
  • Helling, R. B., Janes, B. K., Kimball, H., Tran, T., Bundesmann, M., Check, P., Phelan, D., Miller, C. (2002). Toxic Waste Disposal in Escherichia coli. J. Bacteriol. 184: 3699-3703 [Abstract] [Full Text]  
  • Linde, H.-J., Notka, F., Irtenkauf, C., Decker, J., Wild, J., Niller, H.-H., Heisig, P., Lehn, N. (2002). Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae. J Antimicrob Chemother 49: 625-630 [Abstract] [Full Text]  
  • McDonald, L. C., Chen, F.-J., Lo, H.-J., Yin, H.-C., Lu, P.-L., Huang, C.-H., Chen, P., Lauderdale, T.-L., Ho, M. (2001). Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coli in Taiwan and Contributions of Distinct Selective Pressures. Antimicrob. Agents Chemother. 45: 3084-3091 [Abstract] [Full Text]  
  • Jellen-Ritter, A. S., Kern, W. V. (2001). Enhanced Expression of the Multidrug Efflux Pumps AcrAB and AcrEF Associated with Insertion Element Transposition in Escherichia coli Mutants Selected with a Fluoroquinolone. Antimicrob. Agents Chemother. 45: 1467-1472 [Abstract] [Full Text]  
  • Wang, H., Dzink-Fox, J. L., Chen, M., Levy, S. B. (2001). Genetic Characterization of Highly Fluoroquinolone-Resistant Clinical Escherichia coli Strains from China: Role of acrR Mutations. Antimicrob. Agents Chemother. 45: 1515-1521 [Abstract] [Full Text]  
  • Giraud, E., Leroy-Setrin, S., Flaujac, G., Cloeckaert, A., Dho-Moulin, M., Chaslus-Dancla, E. (2001). Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys. J Antimicrob Chemother 47: 341-343 [Abstract] [Full Text]  
  • Poole, K. (2000). Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria. Antimicrob. Agents Chemother. 44: 2233-2241 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»